Analysen von Michael Leuchten
| 25.11.19 | Roche buy | UBS AG | |
| 21.11.19 | Novo Nordisk Neutral | UBS AG | |
| 19.11.19 | Bayer buy | UBS AG | |
| 18.11.19 | Novo Nordisk Neutral | UBS AG | |
| 14.11.19 | Roche buy | UBS AG | |
| 14.11.19 | Merck Neutral | UBS AG | |
| 11.11.19 | Roche buy | UBS AG | |
| 11.11.19 | AstraZeneca Sell | UBS AG | |
|
Werbung
|
|||
| 07.11.19 | Roche buy | UBS AG | |
| 01.11.19 | Novo Nordisk buy | UBS AG | |
| 31.10.19 | Bayer buy | UBS AG | |
| 30.10.19 | Bayer buy | UBS AG | |
| 29.10.19 | AstraZeneca Sell | UBS AG | |
| 24.10.19 | AstraZeneca Sell | UBS AG | |
| 21.10.19 | Novo Nordisk buy | UBS AG | |
| 21.10.19 | Sartorius vz. Neutral | UBS AG | |
| 16.10.19 | Roche buy | UBS AG | |
| 17.09.19 | Roche buy | UBS AG | |
| 16.09.19 | Roche buy | UBS AG | |
| 10.09.19 | AstraZeneca Sell | UBS AG | |
| 05.09.19 | Bayer buy | UBS AG | |
| 02.09.19 | Novo Nordisk buy | UBS AG | |
| 09.08.19 | Novo Nordisk buy | UBS AG | |
| 08.08.19 | Merck Neutral | UBS AG | |
| 31.07.19 | Bayer buy | UBS AG | |
| 31.07.19 | Novo Nordisk buy | UBS AG | |
| 30.07.19 | Bayer buy | UBS AG | |
| 26.07.19 | Roche buy | UBS AG | |
| 25.07.19 | AstraZeneca Sell | UBS AG | |
| 25.07.19 | Roche Neutral | UBS AG | |
| 19.07.19 | Sartorius vz. Neutral | UBS AG | |
| 16.07.19 | Bayer buy | UBS AG | |
| 02.07.19 | Sartorius vz. Neutral | UBS AG | |
| 28.06.19 | Bayer buy | UBS AG | |
| 18.06.19 | Novo Nordisk buy | UBS AG | |
| 11.06.19 | Novo Nordisk buy | UBS AG | |
| 03.06.19 | AstraZeneca Sell | UBS AG | |
| 14.05.19 | Merck Neutral | UBS AG | |
| 13.05.19 | Merck Neutral | UBS AG | |
| 13.05.19 | AstraZeneca Sell | UBS AG | |
| 07.05.19 | Novo Nordisk buy | UBS AG | |
| 07.05.19 | AstraZeneca Sell | UBS AG | |
| 03.05.19 | Novo Nordisk buy | UBS AG | |
| 26.04.19 | AstraZeneca Sell | UBS AG | |
| 25.04.19 | Merck Neutral | UBS AG | |
| 25.04.19 | Bayer buy | UBS AG | |
| 24.04.19 | Novartis Neutral | UBS AG | |
| 18.04.19 | Sartorius vz. Neutral | UBS AG | |
| 17.04.19 | Roche Neutral | UBS AG | |
| 09.04.19 | Merck Neutral | UBS AG | |